Allergooncology: an expanding research area.

Area of Science:

• Immunology
• Oncology
• Allergy Research

Background:

• The association between allergic diseases and cancer remains a contentious subject in scientific literature.
• Numerous studies present conflicting findings, suggesting either an inverse, neutral, or positive correlation between allergies and cancer incidence.

Discussion:

• Immune cells and molecules integral to allergic reactions exhibit dual roles in tumorigenesis.
• Classically activated M1 macrophages, dendritic cells, IL-33-stimulated ILC2s, Th1, and CD8+ T cells generally inhibit tumor progression.
• Conversely, alternatively activated M2 macrophages, regulatory immune cells, and Th2 lymphocytes can promote carcinogenesis, with some cells like mast cells having context-dependent effects.

Key Insights:

• Specific immune cell subsets, such as M2 macrophages and Th2 lymphocytes, are implicated in both allergic reactions and cancer progression.
• Eosinophils demonstrate a predominantly tumoricidal function through mechanisms involving defensins and cytokines.
• Understanding the specific roles of immune cells in cancer development is crucial.

Outlook:

• Further research into the intricate interplay between allergic and oncogenic processes can guide the development of novel diagnostic and therapeutic strategies.
• Targeting specific immune cell pathways involved in allergy could offer new avenues for cancer treatment and prevention.
• Elucidating the context-dependent functions of immune cells like mast cells is key for future clinical applications.